Population of Men with Advanced Prostate Cancer: Sequencing of Treatment
Arnulf Stenzl, MD, delves into sequencing treatments for prostate cancer and integrating technology and data into patient care.
Read MoreSelect Page
Arnulf Stenzl, MD is Chairman and Professor in the Department of Urology at the Eberhard Karls University of Tuebingen Medical School. Dr. Stenzl earned his MD from the Karl-Franzens University in Graz, Austria.
Dr. Stenzl is author or co-author on more than 800 publications and scientific papers in peer reviewed journals, and he is a member of numerous public and privately initiated steering committees and advisory boards focusing on urologic topics. Dr. Stenzl holds two international patents. Dr. Stenzl has been the Chairman of the Scientific Congress Office of the European Association of Urology (EAU), Adjunct Secretary Science of the EAU and Secretary-elect since 2022. Dr. Stenzl is a Board member of the European Cancer Organization and was president of the German Association of Urology in 2020/2021. He is also on the editorial boards of several journals.
Dr. Stenzl’s major research interests are bladder and prostate cancer and reconstructive urology. He has been awarded the Jackson Hole Award of Excellence in the United States. Additionally Dr. Stenzl is an investigator in numerous clinical trials and has organized numerous national and international symposiums on uro-oncology, particularly prostate and bladder cancer, as well other urologic subjects.
In May 2017 he was granted an honorary degree because of his worldwide recognition and contribution to the development in the field of urology.
Posted by Arnulf Stenzl, MD | Dec 2024
Arnulf Stenzl, MD, delves into sequencing treatments for prostate cancer and integrating technology and data into patient care.
Read MorePosted by Arnulf Stenzl, MD | Jun 2024
Arnulf Stenzl, MD, discusses the challenges of appropriately sequencing advanced prostate cancer treatment and presents possible solutions. In his presentation, he addresses:
Recent and Anticipated Changes in Advanced Prostate Cancer Treatment
The Issue of Physician Information Overload
The Lack of Easily Accessible Comparative Data Between Agents
Possible Applications of Artificial Intelligence in Literature Searches
Posted by Arnulf Stenzl, MD | Aug 2023
Arnulf Stenzl, MD, discusses the future prospects of artificial intelligence (AI) combined with precision surgery and robotics in the diagnosis and treatment of the lower urinary tract. He outlines an intraoperative multisensory approach for tissue differentiation involving sensor development with mechanical, optical, and electric properties. Combined with AI modeling, the result is a scoring system for intraoperative identification of tissue characteristics based on multimodal/multiscale data with tissue differentiation by optical emission spectroscopy.
Dr. Stenzl displays data on the discrimination of tissue based on electrical impedance. He points out the value of discrimination of deeper tissue layers using model-based optical sensors to see and avoid, for example, vessels and nerves. Dr. Stenzl then describes a device for intraoperative real-time elastography, even at the cellular level.
He emphasizes the importance of consistent AI tissue modeling, covering multiple physical domains to combine different sensors and inform the best actions. Dr. Stenzl explains that AI can extract and reproduce features for navigation during surgery. Dr. Stenzl re-emphasizes the importance of precision surgery moving toward intraoperative diagnostics that builds on the traditional standard of frozen section and predicts the further development of precision surgery and AI technologies in the coming years.
Read MorePosted by Arnulf Stenzl, MD | May 2023
Arnulf Stenzl, MD explores robotic-assisted versus open partial nephrectomy for patients with intermediate to high-complexity renal cell carcinoma.
Read More